Treatment of myelodysplastic syndromes (MDS) with recombinant human erythropoietin (rHuEPO): Preliminary clinical results

Clinical Results ◽

Experimental and Clinical Results of Perioperative Treatment with Recombinant Human Erythropoietin

Pathophysiology and Pharmacology of Erythropoietin ◽

10.1007/978-3-642-77074-6_40 ◽

1992 ◽

pp. 315-320 ◽

Cited By ~ 2

Author(s):

O. R. C. Busch ◽

M. A. W. Hoynck van Papendrecht ◽

R. L. Marquet ◽

J. Jeekel

Keyword(s):

Clinical Results ◽

Perioperative Treatment ◽

Effectiveness of Recombinant Human Erythropoietin Therapy in Myelodysplastic Syndromes

Acta Haematologica ◽

10.1159/000204784 ◽

1992 ◽

Vol 87 (1) ◽

pp. 20-24 ◽

Cited By ~ 11

Author(s):

J.W. Adamson ◽

M. Schuster ◽

S. Allen ◽

N.R. Haley

Keyword(s):

The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

British Journal of Haematology ◽

10.1111/j.1365-2141.1991.tb08594.x ◽

1991 ◽

Vol 77 (3) ◽

pp. 419-423 ◽

Cited By ~ 91

Author(s):

David Bowen ◽

Dominc Culligan ◽

Allan Jacobs

Keyword(s):

Treatment of anemia in low risk myelodysplastic syndromes with granulocyte–macrophage colony-stimulating factor plus recombinant human erythropoietin

Leukemia ◽

10.1038/sj.leu.2401442 ◽

1999 ◽

Vol 13 (7) ◽

pp. 1009-1012 ◽

Cited By ~ 16

Author(s):

T Economopoulos ◽

S Mellou ◽

E Papageorgiou ◽

V Pappa ◽

V Kokkinou ◽

...

Keyword(s):

Low Risk ◽

Colony Stimulating Factor ◽

Human Erythropoietin ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment

Annals of Hematology ◽

10.1007/bf01811466 ◽

1992 ◽

Vol 64 (1) ◽

pp. 16-21 ◽

Cited By ~ 34

Author(s):

G. E. G. Verhoef ◽

P. Zachée ◽

A. Ferrant ◽

H. Demuynck ◽

D. Selleslag ◽

...

Keyword(s):

Efficacy of Recombinant Human Erythropoietin in the Treatment of Refractory Anemias Without Excess of Blasts in Myelodysplastic Syndromes

Leukemia & Lymphoma ◽

10.3109/10428199409059603 ◽

1994 ◽

Vol 12 (3-4) ◽

pp. 307-314 ◽

Cited By ~ 9

Author(s):

Françoise Isnard ◽

Myriam Labopin ◽

Jean-Philippe Laporte ◽

Norbert-Claude Gorin ◽

Albert Najman ◽

...

Keyword(s):

Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy

European Journal Of Haematology ◽

10.1111/j.1600-0609.1996.tb00311.x ◽

2009 ◽

Vol 56 (1-2) ◽

pp. 106-108 ◽

Cited By ~ 1

Author(s):

Alessandro Bucalossi ◽

Giuseppe Marotta ◽

Catia Bigazzi ◽

Piero Galieni ◽

Franco Vessichelli ◽

...

Keyword(s):

Functional Classification ◽

Recombinant human erythropoietin (rhEPO) in the management of anemia and fatigue associated with hematologic malignancies and the myelodysplastic syndromes

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155298004004031 ◽

1998 ◽

Vol 4 (4 Suppl) ◽

pp. S12-S17

Author(s):

T. G Davidson

Keyword(s):

Hematologic Malignancies ◽

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution

American Journal of Hematology ◽

10.1002/ajh.22111 ◽

2011 ◽

Vol 86 (9) ◽

pp. 762-767 ◽

Cited By ~ 5

Author(s):

Antonio Azzarà ◽

Giovanni Carulli ◽

Sara Galimberti ◽

Claudia Baratè ◽

Rita Fazzi ◽

...

Keyword(s):

Single Agent ◽

High Dose ◽

Intermediate Risk ◽

Single Institution ◽

Human Erythropoietin ◽

Retrospective Investigation

Recombinant human erythropoietin (rh Epo): A possible treatment for the anemia of myelodysplastic syndromes (MDS)

Leukemia Research ◽

10.1016/0145-2126(91)90451-x ◽

1991 ◽

Vol 15 ◽

pp. 32

Author(s):

F. Ismard ◽

P. Fenaux ◽

B. Jaar ◽

J.Ph. Laporte ◽

J. Deloux ◽

...

Keyword(s):